MedTrace Logo

Evaluating System Change to Advance Learning and Take Evidence to Scale (ESCALATES)

NCT02560428 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 7

Last updated 2024-06-03

No results posted yet for this study

Summary

The purpose of this study is to evaluate approximately eight grants that will test interventions to improve cardiovascular disease prevention. The investigators will collect and analyze qualitative data to identify the most effective combinations of intervention strategies. The investigators will observe grantees and selected practices to understand why and how those combinations are effective. The investigators will also gather data from the grantees to assess how effective the interventions are.

Conditions

  • Program Evaluation

Interventions

BEHAVIORAL

ESCALATES

The investigators collect and analyze qualitative data to identify the most effective combinations of intervention strategies for various practice types, contexts, and organizational characteristics, and to understand why and how those combinations are effective. The investigators also gather de-identified quantitative data that the R18s collected.

Sponsors & Collaborators

  • University of Texas

    collaborator OTHER

  • Rutgers University

    collaborator OTHER

  • HealthPartners Institute

    collaborator OTHER

  • University of Michigan

    collaborator OTHER

  • Case Western Reserve University

    collaborator OTHER

  • Oregon Health and Science University

    lead OTHER

Principal Investigators

  • Debbie Cohen, PhD · OHSU, Department of Family Medicine

Eligibility

Min Age
18 Years
Max Age
89 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2015-04-30
Primary Completion
2022-04-30
Completion
2022-04-30

More Related Trials

Entities

Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02560428 on ClinicalTrials.gov